Jiménez, D.J.; Javed, A.; Rubio-Tomás, T.; Seye-Loum, N.; Barceló, C.
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. Int. J. Mol. Sci. 2024, 25, 2860.
https://doi.org/10.3390/ijms25052860
AMA Style
Jiménez DJ, Javed A, Rubio-Tomás T, Seye-Loum N, Barceló C.
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences. 2024; 25(5):2860.
https://doi.org/10.3390/ijms25052860
Chicago/Turabian Style
Jiménez, Diego J., Aadil Javed, Teresa Rubio-Tomás, Ndioba Seye-Loum, and Carles Barceló.
2024. "Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer" International Journal of Molecular Sciences 25, no. 5: 2860.
https://doi.org/10.3390/ijms25052860
APA Style
Jiménez, D. J., Javed, A., Rubio-Tomás, T., Seye-Loum, N., & Barceló, C.
(2024). Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences, 25(5), 2860.
https://doi.org/10.3390/ijms25052860